Yazar "Saglam E.K." için listeleme
-
Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study
Saglam S.; Bugra D.; Saglam E.K.; Asoglu O.; Balik E.; Yamaner S.; Bulut T. (Pioneer Bioscience Publishing, 2014)Background and purpose: The optimum duration between neoadjuvant radiochemotherapy and transmesorectal excision in locally advanced rectal cancer has not been defined yet. This randomized study was designed to compare the ... -
Neoadjuvant hyperfractionated-accelerated radiotherapy with concomitant chemotherapy in esophageal cancer: Phase II study
Saglam S.; Arifoglu A.; Saglam E.K.; Tunca F.; Asoglu O.; Engin G.; Yamaner S. (Pioneer Bioscience Publishing, 2013)Purpose: Concomitant use of chemotherapy and a radiation dose schedule that is more efficient compared to conventional radiotherapy may provide better outcomes in patients with esophageal cancer. This study aimed to assess ...